Ranitidine hydrochloride and Formoterol fumarate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine hydrochloride (ranitidine hydrochloride) and Formoterol fumarate (formoterol fumarate). Common drug interactions include drug ineffective among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine hydrochloride and Formoterol fumarate. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

What is Formoterol fumarate?

Formoterol fumarate has active ingredients of formoterol fumarate. eHealthMe is studying from 4,967 Formoterol fumarate users. Check the latest studies of Formoterol fumarate.

On Jul, 06, 2026

37 people who take Ranitidine hydrochloride and Formoterol fumarate together, and have interactions are studied.

Ranitidine hydrochloride and Formoterol fumarate drug interactions.

What are the common drug interactions of Ranitidine Hydrochloride and Formoterol Fumarate, by gender? *:

female:

Drug ineffective
Asthma
Cough
Dyspnoea (difficult or laboured respiration)
Pneumonia
Fatigue (feeling of tiredness)
Abdominal pain upper
Anaemia (lack of blood)
Asthenia (weakness)
Blood calcium increased

male:

Asthma
Hospitalisation
Cerebral atrophy (decrement in size of brain)
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Chorea (abnormal involuntary movement disorder)
Chronic kidney disease
Constipation
Cough
Dementia (madness)

What are the common drug interactions of Ranitidine Hydrochloride and Formoterol Fumarate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal distension
Abdominal pain
Chronic kidney disease
Diarrhoea
Dysuria (painful or difficult urination)
Fatigue (feeling of tiredness)
Micturition urgency (urgency to pass the urine)
Nocturia (the need to get up in the night to urinate)
Renal failure (kidney dysfunction)
Renal pain (kidney pain)

50-59:

n/a

60+:

Asthma
Cough
Blood calcium increased
Blood creatinine increased
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Bronchopulmonary aspergillosis allergic (allergic lung disorder caused by aspergillus fungi)
Drug hypersensitivity
Fatigue (feeling of tiredness)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Headache (pain in head)

What are the existing conditions these people have? *

Asthma: 28 people, 75.68%
Dyspnea (difficult or laboured breathing): 16 people, 43.24%
Constipation: 15 people, 40.54%
The Flu (the flu is caused by an influenza virus): 5 people, 13.51%
Pain: 2 people, 5.41%
Device Related Infection: 2 people, 5.41%
Anaemia (lack of blood): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and Formoterol fumarate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously